These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1198 related articles for article (PubMed ID: 18425913)

  • 1. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease.
    Dalbello-Haas V; Florence JM; Krivickas LS
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005229. PubMed ID: 18425913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease.
    Dal Bello-Haas V; Florence JM
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD005229. PubMed ID: 23728653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease.
    Ashworth NL; Satkunam LE; Deforge D
    Cochrane Database Syst Rev; 2012 Feb; (2):CD004156. PubMed ID: 22336799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease.
    Ashworth NL; Satkunam LE; Deforge D
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004156. PubMed ID: 16437474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease.
    Ashworth NL; Satkunam LE; Deforge D
    Cochrane Database Syst Rev; 2004; (1):CD004156. PubMed ID: 14974059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron disease.
    Guo J; Zhou M; Yang M; Zhu C; He L
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008554. PubMed ID: 21901724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease.
    Diana A; Pillai R; Bongioanni P; O'Keeffe AG; Miller RG; Moore DH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006049. PubMed ID: 28067943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron disease.
    Fang J; Zhou M; Yang M; Zhu C; He L
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD008554. PubMed ID: 23728676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease.
    Baldinger R; Katzberg HD; Weber M
    Cochrane Database Syst Rev; 2012 Apr; (4):CD004157. PubMed ID: 22513921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.
    Radunovic A; Annane D; Rafiq MK; Mustfa N
    Cochrane Database Syst Rev; 2013 Mar; (3):CD004427. PubMed ID: 23543531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.
    Abdul Wahid SF; Law ZK; Ismail NA; Lai NM
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011742. PubMed ID: 31853962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.
    Radunovic A; Annane D; Rafiq MK; Brassington R; Mustfa N
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD004427. PubMed ID: 28982219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.
    Radunovic A; Annane D; Jewitt K; Mustfa N
    Cochrane Database Syst Rev; 2009 Oct; (4):CD004427. PubMed ID: 19821325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease.
    Gibbons C; Pagnini F; Friede T; Young CA
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011005. PubMed ID: 29293261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease.
    Brettschneider J; Kurent J; Ludolph A; Mitchell JD
    Cochrane Database Syst Rev; 2008 Jul; (3):CD005226. PubMed ID: 18646122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease.
    Beauverd M; Mitchell JD; Wokke JH; Borasio GD
    Cochrane Database Syst Rev; 2012 Nov; 11():CD002064. PubMed ID: 23152212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods for informing people with amyotrophic lateral sclerosis/motor neuron disease of their diagnosis.
    Bongioanni P; Borasio GD; Oliver DJ; Romagnoli A; Kapitza KP; Sidle K; Tramonti F
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD007593. PubMed ID: 36812393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease.
    Ng L; Khan F; Young CA; Galea M
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011776. PubMed ID: 28072907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease.
    Mitchell JD; Wokke JH; Borasio GD
    Cochrane Database Syst Rev; 2007 Oct; (4):CD002064. PubMed ID: 17943766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acids for amyotrophic lateral sclerosis / motor neuron disease.
    Parton M; Mitsumoto H; Leigh PN
    Cochrane Database Syst Rev; 2003; (4):CD003457. PubMed ID: 14583978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.